Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-22 to 2024-05-23
Current total value of award: $16122.51
Description: 4564690019!ADBRY 150 MG/ML SYRINGEML